QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

XENE

QT52Xenon Pharmaceuticals Inc.
NASDAQ·Healthcare·Biotechnology·Canada
Latest market price
52.91
-0.29-0.55%
OverviewShort InterestFilings
XENEQT52Xenon Pharmaceuticals Inc.·NASDAQ
OverviewShort InterestFilings
52.91-0.55%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.90
Insider Own2.55%
Shs Outstand96.67M
Perf Week1.38%
Market Cap4.20BForward P/E-EPS next Y-4.89Insider Trans0.45%Shs Float-Perf Month-2.11%
Enterprise Value3.66BPEG0.36EPS next Q-1.16Inst Own-Short Float-Perf Quarter-4.10%
Income-346499998.00P/S0.00EPS this Y-150.10%Inst Trans-Short Ratio-Perf Half Y23.05%
Sales-P/B3.47EPS next Y-2.89%ROA-27.63%Short Interest-Perf YTD18.05%
Book/sh13.84P/C-EPS next 5Y-ROE-49.23%52W High63.95 -17.26%Perf Year66.91%
Cash/sh11.33P/FCF-EPS past 3/5Y-ROIC-30.44%52W Low30.00 76.37%Perf 3Y-
Dividend Est.-EV/EBITDA-9.18Sales past 3/5Y-3.85% -24.21%Gross Margin0.00%Volatility2.00% 2.21%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-56.15%Oper. Margin0.00%ATR (14)1.69Perf 10Y-
Dividend Ex-Date-Quick Ratio27.79Sales Y/Y TTM-Profit Margin0.00%RSI (14)47.54Recom2.00
Dividend Gr. 3/5Y-Current Ratio27.79EPS Q/Q-40.96%SMA20-0.14%Beta1.03Target Price85.00
Payout0.00%Debt/Eq0.01Sales Q/Q-100.00%SMA50-3.97%Rel Volume2.09Prev Close53.20
Employees316LT Debt/Eq0.01EarningsAug 10SMA20013.91%Avg Volume1.13MPrice52.91
IPO DateNov 05, 2014Option/ShortYes / YesEPS/Sales Surpr.0.00% -Net Debt/EBITDA1.35Volume2,370,188Change-0.55%
Analyst Ratings
DateActionAnalystRatingTarget
May-10-26ReiteratedWells FargoOverweight$68 → $69
May-08-26ReiteratedNeedhamBuy$78
Mar-10-26ReiteratedDeutsche BankBuy$90
Mar-09-26ReiteratedRBC CapitalOutperform$59 → $80
Mar-09-26ReiteratedJefferiesBuy$65 → $100
Mar-09-26ReiteratedGuggenheimBuy$49 → $90
Mar-09-26ReiteratedMorgan Stanley$97
Mar-09-26ReiteratedRobert W. Baird$97
Mar-09-26ReiteratedStifel NicolausBuy$66 → $89
Feb-23-26InitiatedWolfe ResearchOutperform$60
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2280
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A8233
Gross Profit-625-3
Selling, General and Administrative Excl. Other288069
Research and Development82301210
Other Operating Expense-82-3-2
Operating Income-88-373-279
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)0-28-41
Net Income Before Taxes-30-345-238
Income Taxes01-4
Consolidated Net Income-92-346-234
Net Income From Continuing Operations-92-346-234
Net Income-92-346-234
EPS (Recurring)-1.91-4.36-3.01
EPS (Basic, Before Extraordinaries)-1.91-4.36-3.01
EPS (Diluted)-1.90-4.36-3.01
EBITDA-87-342-236
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio134.68442.60—
Gross Margin-281.8262.50—
Operating Margin-400.00-4,662.50—
Net Margin-418.18-4,325.00—
Shares Outstanding567978
Market Capitalization2,9633,541—
Operating Lease Expense
———
Insider Trading Volume
$56.33$49.73$43.13$36.52$29.92● Close Price0.00M4.46M8.92M13.38M17.85MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
PATOU GARYDirectorJun 05 '26Sale53.141,32270,25124,896Jun 08 12:00 AM
Cannon GillianDirectorJun 05 '26Sale53.141,19063,2371,455Jun 08 12:00 AM
PATOU GARYDirectorJun 01 '26Option Exercise0.005,290026,218Jun 03 12:00 AM
Machado PatrickDirectorJun 01 '26Option Exercise0.005,29002,645Jun 03 12:00 AM
Gover Justin D.DirectorJun 01 '26Option Exercise0.005,29002,645Jun 03 12:00 AM
GAROFALO ELIZABETH A.DirectorJun 01 '26Option Exercise0.005,29002,645Jun 03 12:00 AM
GANNON STEVENDirectorJun 01 '26Option Exercise0.005,290013,286Jun 03 12:00 AM
Cannon GillianDirectorJun 01 '26Option Exercise0.005,29002,645Jun 03 12:00 AM
Svoronos DawnDirectorJun 01 '26Option Exercise0.005,290027,645Jun 03 12:00 AM
GANNON STEVENDirectorMay 12 '26Option Exercise7.387,00051,66010,641May 13 12:00 AM
DiFabio AndreaChief Legal OfficerMar 13 '26Sale55.231,34274,1127,301Mar 13 12:00 AM
KENNEY CHRISTOPHER JOHNChief Medical OfficerMar 13 '26Sale55.231,41077,8677,069Mar 13 12:00 AM
MORTIMER IANPRESIDENT & CEOMar 13 '26Sale55.237,308403,58419,923Mar 13 12:00 AM
DiFabio AndreaChief Legal OfficerMar 12 '26Option Exercise0.007,500011,250Mar 13 12:00 AM
KENNEY CHRISTOPHER JOHNChief Medical OfficerMar 12 '26Option Exercise0.007,500011,250Mar 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR